Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 26.09.2024
Hardman & Co Research
Hardman & Co Research on Chesnara Plc (CSN): Steady as she goes!
Chesnara has announced its 1H’24 results. The main features were positive equity market returns, offset to some extent by further adverse lapse experience. Economic Value profit of £20.2m was behind the 1H’23 result of £32.6m (excl. acquisitions). Economic Value saw a small de [ … ]
Thu, 26.09.2024
INDUS Holding AG
Company Name:
INDUS Holding AG
ISIN:
DE0006200108
Reason for the research:
Update
Recommendation:
BUY
from:
26.09.2024
Target price:
EUR 34.00
Last rating change:
Analyst:
Christian Sandherr
New value accretive deals should fuel long-term growthTopic: INDUS is working at full speed on its well filled M&A pipeline and closed [ … ]
Thu, 26.09.2024
Commerzbank Aktiengesellschaft
Chairman of the Supervisory Board Jens Weidmann: Commerzbank has considerable potential for growth and appreciation
The Board of Management expects faster and stronger improvements in profitability: Return on equity is expected to rise to more than 12% by 2027
Increased and accelerated capital return to shareholders planned
During the annual stra [ … ]
Thu, 26.09.2024
Vectron Systems AG
The new majority shareholder, the Shift4 group, informed the company today that it intends to initiate the process for concluding a domination and profit loss transfer agreement between Vectron Systems AG as a dependent company and its majority shareholder.
Contact:
External IR service provider:
Meister Consulting GmbH
Im Schling 3
59955 Winterber [ … ]
Thu, 26.09.2024
ABIVAX
Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024
Professor Bruce E. Sands, MD to present oral presentation of Phase 2b, open-label, maintenance efficacy and safety data at weeks 48 and 96 among week 8 induction non-responders in obefazimod-treated patients with moderately to severely active ulcerative col [ … ]
Thu, 26.09.2024
Golding Capital Partners GmbH
Golding continues successful buyout strategy and closes flagship “Golding Buyout 2021” at €250 million
Munich, 26 September 2024 – Golding Capital Partners has announced the final closing of its Article 8 fund “Golding Buyout 2021” with capital commitments totalling €250 million. The successful continuation of the established buyout series in its [ … ]
Thu, 26.09.2024
Veganz Group AG
EQS-News: Veganz Group AG
/ Key word(s): Half Year Results
Decline in sales due to product range measures in the 1st half of 2024
26.09.2024 / 08:17 CET/CEST
Thu, 26.09.2024
Veganz Group AG
Veganz and US investment bank DelMorgan conclude agreement to issue a hybrid equity bond
Ludwigsfelde, 26 September 2024 - Veganz Group AG, with the support of the family office Sterling Atlantic LLC based in Santa Monica (USA), which already subscribed a €10m equity financing for Veganz Group AG a few weeks ago, has concluded an agreement to [ … ]
Thu, 26.09.2024
Veganz Group AG
Disclosure of inside information pursuant to Article 17 (1) of the Regulation (EU) 596/2014 on market abuse (market abuse regulation)
NOT FOR RELEASE, PUBLICATION, DISTRIBUTION, DISSEMINATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH [ … ]
Thu, 26.09.2024
Verbio SE
Verbio achieves forecast earnings in FY 2023/24 and marks important milestones
EBITDA of EUR 121.6 million for FY 2023/24, within the forecast range
Significant improvement in earnings in Q4 2023/24
Verbio welcomes advances in the fight against climate fraud
Proposed dividend of EUR 0.20 per share
Leipzig, September 26, 2024 – Verbio has been a [ … ]